Showing 20 of 33 recruiting trials for “Multiple system atrophy”
MSA-01 in Multiple System Atrophy
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
👨⚕️ Teva Medical Expert, MD, Teva Branded Pharmaceutical Products R&D LLC📍 5 sites📅 Started Sep 2025View details ↗
Enrolling by InvitationNCT07081841 ↗
AB-1005 Long-Term Follow-up Study
Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
👨⚕️ Yilong Wang, M.D., Beijing Tiantan Hospital, Capital Medical University, Beijing, China📍 1 site📅 Started May 2025View details ↗
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
RecruitingNCT07353463 ↗
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
[18F]ACI-15916 PET in α-synucleinopathies
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
👨⚕️ Tev Medical Expert, Study Director, Teva Branded Pharmaceutical Products R&D LLC📍 54 sites📅 Started Oct 2024View details ↗
RecruitingNCT06890390 ↗
TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy
Enrolling by InvitationNCT06745011 ↗
Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System
👨⚕️ Astrid J. Terkelsen, MD, DrMedSc, PhD, Professor, Department of clinical medicine, Aarhus University and Department of Neurology, Aarhus University Hospital📍 1 site📅 Started May 2024View details ↗
PET Imaging Evaluation of [11C]SY08
Transcutaneous Spinal Cord Stimulation Home Study
👨⚕️ Michael J Berger, MD, FRCPC, The University of British Columbia📍 1 site📅 Started Feb 2024View details ↗
[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD
👨⚕️ Koen Van Laere, Professor at KULeuven, department head of nuclear medicine at UZ Leuven📍 2 sites📅 Started Jan 2024View details ↗
Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
Therapeutic Education for Multiple System Atrophy (MSA) Patients and Their Caregivers
RecruitingNCT05826457 ↗
North American Prodromal Synucleinopathy Consortium Stage 2
👨⚕️ Yo-El Ju, MD, MCSI, Washington University School of Medicine📍 9 sites📅 Started Aug 2022View details ↗
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →